• Corpus ID: 37405255

[Determination of gelsemium alkaloids by RP-HPLC].

@article{Luo1993DeterminationOG,
  title={[Determination of gelsemium alkaloids by RP-HPLC].},
  author={S R Luo and T Li and J. S. Yang},
  journal={Yao xue xue bao = Acta pharmaceutica Sinica},
  year={1993},
  volume={28 9},
  pages={
          695-8
        }
}
Gelsemium elegans Benth is a kind of traditional Chinese medicine, eight alkaloids have been isolated from this herb. In recent years, an HPLC method for the separation and determination of five of these alkaloids, ie. gelsemium A (G), koumine (F), kumantenidine (D), kumantenine (B) and kumantenmine (A) is described, dichroine being used as the internal standard. In this report a RP column of C18 and the mobile phase methanol--water--n-butylamine (78:22:0.1 V/V) were employed. The flow rate was… 
Confirmation of gelsemium poisoning by targeted analysis of toxic gelsemium alkaloids in urine.
TLDR
A novel liquid chromatography-tandem mass spectrometry protocol was optimized for the collective detection of gelsemine and related alkaloids from Gelsemium elegans and sustained as the main urinary marker of G Elsemium exposure.
A Study of the in vitro cytotoxic activity of Gelsemium elegans using human ovarian and breast cancer cell lines.
TLDR
The results demonstrated that G. elegans is potently cytotoxic against the human ovarian cancer cell line CaOV-3 and to a lesser extend towards the human breast carcinoma cancer MDA-MB-231 cells, suggesting that the extract is selective towards Caov-3 cells and may have a chemotherapeutic role for ovarian cancer treatment in the future.
A Study of the in vitro cytotoxic activity of Gelsemium elegans using human ovarian and breast cancer cell lines.
TLDR
The results demonstrated that G. elegans is potently cytotoxic against the human ovarian cancer cell line CaOV-3 and to a lesser extend towards the human breast carcinoma cancer MDA-MB-231 cells, suggesting that the extract is selective towards Caov-3 cells and may have a chemotherapeutic role for ovarian cancer treatment in the future.